Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$64,625,993
+$12,767,401 QoQ
Shares Held
4,069,647
+6.0% QoQ
Ownership
0.354%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#39
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $776,969,626 across 46 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,567,388 | $256,352,500 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,916,666 | $132,696,643 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
207,093 | $112,209,199 | |
| 4 | VTRS |
Viatris Inc
This page
|
4,069,647 | $64,625,993 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
314,451 | $52,997,570 | |
| 6 | ALKS |
Alkermes plc.
|
393,524 | $20,620,657 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
711,233 | $17,503,443 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,012,792 | $15,941,311 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,625,993 | 4,069,647 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $51,858,592 | 3,838,534 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $44,641,316 | 3,585,648 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $40,698,117 | 4,110,921 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $57,489,714 | 6,437,818 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $75,014,134 | 8,612,415 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $105,195,414 | 8,449,431 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $111,107,095 | 9,569,948 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $104,100,757 | 9,793,110 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $108,553,929 | 9,091,619 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $98,773,897 | 9,120,397 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $89,127,399 | 9,039,290 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $92,723,491 | 9,290,931 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $83,628,025 | 8,693,142 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $95,317,742 | 8,564,038 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $73,836,663 | 8,666,275 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $91,821,480 | 8,769,960 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $91,134,905 | 8,376,370 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $103,628,434 | 7,659,160 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $107,779,232 | 7,954,187 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $118,914,019 | 8,321,485 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $120,218,736 | 8,605,493 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $163,394,414 | 8,719,019 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||